{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T01:03:15Z","timestamp":1791421395494,"version":"4.3.3"},"reference-count":157,"publisher":"European Respiratory Society (ERS)","issue":"176","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["Eur Respir Rev"],"accepted":{"date-parts":[[2025,3,30]]},"published-print":{"date-parts":[[2025,4]]},"abstract":"<jats:p>Dipeptidyl peptidase (DPP)-1 (also known as cathepsin C) inhibitors are the first disease-specific therapy shown to be effective in bronchiectasis. The mechanism of action of DPP-1 inhibitors is suppression of activity of neutrophil serine proteases (NSPs) by preventing them from being activated during neutrophil maturation in the bone marrow. NSPs exert multiple directly damaging effects and contribute to ongoing dysregulated airway inflammation. High airway levels of NSPs are linked to bronchiectasis disease severity. Several phase 2 and one phase 3 trial have now confirmed that DPP-1 inhibitors reduce activity of the NSPs in the airways and have clinical benefits in bronchiectasis including reducing exacerbations and improving other clinical end-points such as quality of life and slowing lung function decline. DPP-1 inhibition may also be a promising treatment avenue in other diseases where neutrophilic inflammation is implicated. Future directions include establishing direct and downstream effects of DPP-1 inhibitors in humans and seeking biomarkers to guide clinical application.<\/jats:p>","DOI":"10.1183\/16000617.0257-2024","type":"journal-article","created":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T04:25:11Z","timestamp":1750220711000},"page":"240257","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":21,"title":["Dipeptidyl peptidase-1 inhibitors in bronchiectasis"],"prefix":"10.1183","volume":"34","author":[{"given":"Emma","family":"Johnson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Gilmour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James D.","family":"Chalmers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2025,6,18]]},"reference":[{"key":"2025061801250786000_34.176.240257.1","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00003709"},{"key":"2025061801250786000_34.176.240257.2","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2014-205918"},{"key":"2025061801250786000_34.176.240257.3","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1056\/NEJMoa2411664","article-title":"Phase 3 trial of the DPP-1 inhibitor brensocatib in bronchiectasis","volume":"392","author":"Chalmers","year":"2025","journal-title":"N Engl J Med"},{"key":"2025061801250786000_34.176.240257.4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2021713"},{"key":"2025061801250786000_34.176.240257.5","doi-asserted-by":"crossref","first-page":"2401551","DOI":"10.1183\/13993003.01551-2024","article-title":"Cathepsin C (dipeptidyl peptidase 1) inhibition in adults with bronchiectasis: AIRLEAF, a phase II randomised, double-blind, placebo-controlled, dose-finding study","volume":"65","author":"Chalmers","year":"2024","journal-title":"Eur Respir J"},{"key":"2025061801250786000_34.176.240257.6","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2018-212463"},{"key":"2025061801250786000_34.176.240257.7","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00629-2017"},{"key":"2025061801250786000_34.176.240257.8","doi-asserted-by":"crossref","first-page":"21","DOI":"10.5694\/mja14.00287","article-title":"Chronic suppurative lung disease and bronchiectasis in children and adults in Australia and New Zealand Thoracic Society of Australia and New Zealand guidelines","volume":"202","author":"Chang","year":"2015","journal-title":"Med J Aust"},{"key":"2025061801250786000_34.176.240257.9","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)31767-7"},{"key":"2025061801250786000_34.176.240257.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2020.02.038"},{"key":"2025061801250786000_34.176.240257.11","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-019-0054-z"},{"key":"2025061801250786000_34.176.240257.12","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.1112571"},{"key":"2025061801250786000_34.176.240257.13","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-01-259028"},{"key":"2025061801250786000_34.176.240257.14","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3389\/fcimb.2017.00159","article-title":"Influence of microbes on neutrophil life and death","volume":"7","author":"Kobayashi","year":"2017","journal-title":"Front Cell Infect Microbiol"},{"key":"2025061801250786000_34.176.240257.15","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/642503"},{"key":"2025061801250786000_34.176.240257.16","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(20)30504-X"},{"key":"2025061801250786000_34.176.240257.17","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201712-2423OC"},{"key":"2025061801250786000_34.176.240257.18","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.201006052"},{"key":"2025061801250786000_34.176.240257.19","doi-asserted-by":"publisher","DOI":"10.1126\/science.1092385"},{"key":"2025061801250786000_34.176.240257.20","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2016-0193PS"},{"key":"2025061801250786000_34.176.240257.21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0023637"},{"key":"2025061801250786000_34.176.240257.22","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201605-1027OC"},{"key":"2025061801250786000_34.176.240257.23","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00769-2020"},{"key":"2025061801250786000_34.176.240257.24","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200208-829OC"},{"key":"2025061801250786000_34.176.240257.25","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01702-2020"},{"key":"2025061801250786000_34.176.240257.26","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00303-2019"},{"key":"2025061801250786000_34.176.240257.27","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1164\/rccm.202310-1729OC","article-title":"Endotypes of exacerbation in bronchiectasis an observational cohort study","volume":"210","author":"Gao","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"2025061801250786000_34.176.240257.28","doi-asserted-by":"publisher","DOI":"10.1172\/JCI113816"},{"key":"2025061801250786000_34.176.240257.29","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.bbrc.2018.07.038","article-title":"Lung tissue destruction by proteinase 3 and cathepsin G mediated elastin degradation is elevated in chronic obstructive pulmonary disease","volume":"503","author":"Gudmann","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"key":"2025061801250786000_34.176.240257.30","doi-asserted-by":"publisher","DOI":"10.1021\/bi00392a025"},{"key":"2025061801250786000_34.176.240257.31","doi-asserted-by":"crossref","first-page":"9540","DOI":"10.1016\/S0021-9258(18)92854-1","article-title":"Characterization of proteinase-3 (PR-3), a neutrophil serine proteinase. Structural and functional properties","volume":"266","author":"Rao N","year":"1991","journal-title":"J Biol Chem"},{"key":"2025061801250786000_34.176.240257.32","doi-asserted-by":"publisher","DOI":"10.1002\/alr.22401"},{"key":"2025061801250786000_34.176.240257.33","doi-asserted-by":"crossref","first-page":"C603","DOI":"10.1152\/ajpcell.1988.255.5.C603","article-title":"Neutrophil cathepsin G increases permeability of cultured type II pneumocytes","volume":"255","author":"Rochat","year":"1988","journal-title":"Am J Physiol"},{"key":"2025061801250786000_34.176.240257.34","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00022.2006"},{"key":"2025061801250786000_34.176.240257.35","doi-asserted-by":"publisher","DOI":"10.1080\/10409230701340019"},{"key":"2025061801250786000_34.176.240257.36","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.02360"},{"key":"2025061801250786000_34.176.240257.37","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.10014"},{"key":"2025061801250786000_34.176.240257.38","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2014.04.015"},{"key":"2025061801250786000_34.176.240257.39","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1111\/resp.12582","article-title":"Sputum matrix metalloproteinase-8 and -9 and tissue inhibitor of metalloproteinase-1 in bronchiectasis: clinical correlates and prognostic implications","volume":"20","author":"Guan","year":"2015","journal-title":"Respirology"},{"key":"2025061801250786000_34.176.240257.40","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00212114"},{"key":"2025061801250786000_34.176.240257.41","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2021.11.014"},{"key":"2025061801250786000_34.176.240257.42","doi-asserted-by":"publisher","DOI":"10.1378\/chest.107.6.1641"},{"key":"2025061801250786000_34.176.240257.43","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201411-513OC"},{"key":"2025061801250786000_34.176.240257.44","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-72667-3"},{"key":"2025061801250786000_34.176.240257.45","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)62040-8"},{"key":"2025061801250786000_34.176.240257.46","doi-asserted-by":"publisher","DOI":"10.1165\/ajrcmb.20.4.3371"},{"key":"2025061801250786000_34.176.240257.47","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1152\/ajplung.00140.2004","article-title":"Neutrophil elastase induces mucus cell metaplasia in mouse lung","volume":"287","author":"Voynow","year":"2004","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2025061801250786000_34.176.240257.48","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-013-1572-3"},{"key":"2025061801250786000_34.176.240257.49","doi-asserted-by":"publisher","DOI":"10.1165\/ajrcmb.26.4.4473"},{"key":"2025061801250786000_34.176.240257.50","first-page":"L835","article-title":"Neutrophil elastase increases MUC5AC mRNA and protein expression in respiratory epithelial cells","volume":"276","author":"Voynow","year":"1999","journal-title":"Am J Physiol"},{"key":"2025061801250786000_34.176.240257.51","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1164\/rccm.201906-1219OC","article-title":"Airway mucus hyperconcentration in non\u2013cystic fibrosis bronchiectasis","volume":"201","author":"Ramsey","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"2025061801250786000_34.176.240257.52","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.03156-2020"},{"key":"2025061801250786000_34.176.240257.53","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200213572"},{"key":"2025061801250786000_34.176.240257.54","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1200600"},{"key":"2025061801250786000_34.176.240257.55","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200808-1250OC"},{"key":"2025061801250786000_34.176.240257.56","doi-asserted-by":"publisher","DOI":"10.1172\/JCI114699"},{"key":"2025061801250786000_34.176.240257.57","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2003.014902"},{"key":"2025061801250786000_34.176.240257.58","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1301920"},{"key":"2025061801250786000_34.176.240257.59","doi-asserted-by":"publisher","DOI":"10.1124\/pr.110.002733"},{"key":"2025061801250786000_34.176.240257.60","doi-asserted-by":"publisher","DOI":"10.1038\/nri1841"},{"key":"2025061801250786000_34.176.240257.61","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1021\/bi981294s","article-title":"Amino-terminal processing of chemokine ENA-78 regulates biological activity","volume":"38","author":"Nufer","year":"1998","journal-title":"Biochemistry"},{"key":"2025061801250786000_34.176.240257.62","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.aax3053"},{"key":"2025061801250786000_34.176.240257.63","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2009.10.003"},{"key":"2025061801250786000_34.176.240257.64","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2005.03.015"},{"key":"2025061801250786000_34.176.240257.65","doi-asserted-by":"publisher","DOI":"10.1007\/BF02256548"},{"key":"2025061801250786000_34.176.240257.66","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-5793(03)00482-4"},{"key":"2025061801250786000_34.176.240257.67","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.157.3.9606120"},{"key":"2025061801250786000_34.176.240257.68","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0511206103"},{"key":"2025061801250786000_34.176.240257.69","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-018-0883-z"},{"key":"2025061801250786000_34.176.240257.70","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.270.40.23688"},{"key":"2025061801250786000_34.176.240257.71","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.11.6261"},{"key":"2025061801250786000_34.176.240257.72","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-12-4942"},{"key":"2025061801250786000_34.176.240257.73","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2007.08.013"},{"key":"2025061801250786000_34.176.240257.74","doi-asserted-by":"crossref","first-page":"17023","DOI":"10.1038\/sigtrans.2017.23","article-title":"NF-\u03baB signaling in inflammation","volume":"2","author":"Liu","year":"2017","journal-title":"Signal Transduct Target Ther"},{"key":"2025061801250786000_34.176.240257.75","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41392-024-01757-9","article-title":"NF-\u03baB in biology and targeted therapy: new insights and translational implications","volume":"9","author":"Guo","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"2025061801250786000_34.176.240257.76","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00347.2013"},{"key":"2025061801250786000_34.176.240257.77","doi-asserted-by":"crossref","first-page":"651","DOI":"10.3390\/ijms21020651","article-title":"Potent and broad but not unselective cleavage of cytokines and chemokines by human neutrophil elastase and proteinase 3","volume":"21","author":"Fu","year":"2020","journal-title":"Int J Mol Sci"},{"key":"2025061801250786000_34.176.240257.78","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2007.11.008"},{"key":"2025061801250786000_34.176.240257.79","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/0-306-46826-3_43","article-title":"Inactivation of interleukin-6 by neutrophil proteases at sites of inflammation","volume":"2","author":"Bank","year":"2002","journal-title":"Adv Exp Med Biol"},{"key":"2025061801250786000_34.176.240257.80","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2018.02.062"},{"key":"2025061801250786000_34.176.240257.81","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0901716"},{"key":"2025061801250786000_34.176.240257.82","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2015.12.001"},{"key":"2025061801250786000_34.176.240257.83","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1165\/ajrcmb\/8.6.612","article-title":"Interaction of secretory leukocyte protease inhibitor with proteinase-3","volume":"8","author":"Rao","year":"2012","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2025061801250786000_34.176.240257.84","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M803707200"},{"key":"2025061801250786000_34.176.240257.85","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20050768"},{"key":"2025061801250786000_34.176.240257.86","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2018-212895"},{"key":"2025061801250786000_34.176.240257.87","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00148-2015"},{"key":"2025061801250786000_34.176.240257.88","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2013.10.007"},{"key":"2025061801250786000_34.176.240257.89","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2017.03.056"},{"key":"2025061801250786000_34.176.240257.90","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s44231-023-00032-9","article-title":"Effect of sivelestat in the treatment of acute lung injury and acute respiratory distress syndrome: a systematic review and meta-analysis","volume":"3","author":"Ding","year":"2023","journal-title":"Intensive Care Res"},{"key":"2025061801250786000_34.176.240257.91","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2012.12.009"},{"key":"2025061801250786000_34.176.240257.92","doi-asserted-by":"publisher","DOI":"10.1016\/j.pupt.2019.03.009"},{"key":"2025061801250786000_34.176.240257.93","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2018.05.011"},{"key":"2025061801250786000_34.176.240257.94","doi-asserted-by":"publisher","DOI":"10.1016\/S0003-9861(02)00217-5"},{"key":"2025061801250786000_34.176.240257.95","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200213462"},{"key":"2025061801250786000_34.176.240257.96","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M115.707109"},{"key":"2025061801250786000_34.176.240257.97","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1016\/S0021-9258(18)53798-4","article-title":"Generation of active myeloid and lymphoid granule serine proteases requires processing by the granule thiol protease dipeptidyl peptidase I","volume":"268","author":"McGuire","year":"1993","journal-title":"J Biol Chem"},{"key":"2025061801250786000_34.176.240257.98","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M100223200"},{"key":"2025061801250786000_34.176.240257.99","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2020.12.012"},{"key":"2025061801250786000_34.176.240257.100","doi-asserted-by":"publisher","DOI":"10.1038\/70525"},{"key":"2025061801250786000_34.176.240257.101","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.36.12.881"},{"key":"2025061801250786000_34.176.240257.102","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.173.12.7277"},{"key":"2025061801250786000_34.176.240257.103","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.5A1015-489R"},{"key":"2025061801250786000_34.176.240257.104","doi-asserted-by":"publisher","DOI":"10.1172\/JCI76009"},{"key":"2025061801250786000_34.176.240257.105","doi-asserted-by":"publisher","DOI":"10.1021\/jm050686b"},{"key":"2025061801250786000_34.176.240257.106","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2009.07.114"},{"key":"2025061801250786000_34.176.240257.107","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.bcp.2019.04.006","article-title":"Structure-based design and in vivo anti-arthritic activity evaluation of a potent dipeptidyl cyclopropyl nitrile inhibitor of cathepsin C","volume":"164","author":"Korkmaz","year":"2019","journal-title":"Biochem Pharmacol"},{"key":"2025061801250786000_34.176.240257.108","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2017.02.009"},{"key":"2025061801250786000_34.176.240257.109","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00725-2023"},{"key":"2025061801250786000_34.176.240257.110","doi-asserted-by":"crossref","first-page":"9925","DOI":"10.1038\/s41598-019-46206-8","article-title":"Premedication with a cathepsin C inhibitor alleviates early primary graft dysfunction in mouse recipients after lung transplantation","volume":"9","author":"Rehm","year":"2019","journal-title":"Sci Rep"},{"key":"2025061801250786000_34.176.240257.111","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1111\/bcp.13398","article-title":"Epithelial desquamation observed in a phase I study of an oral cathepsin C inhibitor (GSK2793660)","volume":"83","author":"Miller","year":"2017","journal-title":"Br J Clin Pharmacol"},{"key":"2025061801250786000_34.176.240257.112","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.1053"},{"key":"2025061801250786000_34.176.240257.113","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1021\/jm401705g","article-title":"Cathepsin C inhibitors: property optimization and identification of a clinical candidate","volume":"57","author":"Furber","year":"2014","journal-title":"J Med Chem"},{"key":"2025061801250786000_34.176.240257.114","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1002\/cpdd.1094","article-title":"Safety, tolerability, and pharmacokinetic evaluation of single and multiple doses of the dipeptidyl peptidase 1 inhibitor brensocatib in healthy Japanese and White adults","volume":"11","author":"Usansky","year":"2022","journal-title":"Clin Pharmacol Drug Dev"},{"key":"2025061801250786000_34.176.240257.115","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.congress-2023.PA2836"},{"key":"2025061801250786000_34.176.240257.116","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-023-02444-z"},{"key":"2025061801250786000_34.176.240257.117","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-022-01147-w"},{"key":"2025061801250786000_34.176.240257.118","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00695-2022"},{"key":"2025061801250786000_34.176.240257.119","first-page":"277","article-title":"Periodontal effects of the reversible dipeptidyl peptidase 1 inhibitor brensocatib in bronchiectasis","volume":"9","author":"Gunsolley","year":"2024","journal-title":"JDR Clin Trans Res"},{"key":"2025061801250786000_34.176.240257.120","doi-asserted-by":"publisher","DOI":"10.1136\/thorax-2023-BTSabstracts.264"},{"key":"2025061801250786000_34.176.240257.121","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.congress-2023.PA2835"},{"key":"2025061801250786000_34.176.240257.122","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.congress-2024.PA3001"},{"key":"2025061801250786000_34.176.240257.123","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/S2213-2600(25)00019-0","article-title":"Effects of the DPP-1 inhibitor HSK31858 in adults with bronchiectasis in China (SAVE-BE): a phase 2, multicentre, double-blind, randomised, placebo-controlled trial","volume":"13","author":"Zhong","year":"2025","journal-title":"Lancet Respir Med"},{"key":"2025061801250786000_34.176.240257.124","doi-asserted-by":"publisher","DOI":"10.1007\/s00011-023-01774-4"},{"key":"2025061801250786000_34.176.240257.125","doi-asserted-by":"crossref","first-page":"210241","DOI":"10.1183\/16000617.0241-2021","article-title":"Neutrophil extracellular traps in chronic lung disease: implications for pathogenesis and therapy","volume":"31","author":"Keir","year":"2022","journal-title":"Eur Respir J"},{"key":"2025061801250786000_34.176.240257.126","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201906-1190PP"},{"key":"2025061801250786000_34.176.240257.127","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01910-2017"},{"key":"2025061801250786000_34.176.240257.128","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.congress-2023.OA1537"},{"key":"2025061801250786000_34.176.240257.129","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s40272-022-00509-y","article-title":"An update on CFTR modulators as new therapies for cystic fibrosis","volume":"24","author":"King","year":"2022","journal-title":"Pediatr Drugs"},{"key":"2025061801250786000_34.176.240257.130","doi-asserted-by":"crossref","first-page":"2250010","DOI":"10.1002\/eji.202250010","article-title":"Neutrophil activation and neutrophil extracellular traps (NETs) in COVID-19 ARDS and immunothrombosis","volume":"53","author":"Cesta","year":"2023","journal-title":"Eur J Immunol"},{"key":"2025061801250786000_34.176.240257.131","doi-asserted-by":"crossref","first-page":"E330","DOI":"10.1515\/cclm-2021-0137","article-title":"Protease-antiprotease imbalance in patients with severe COVID-19","volume":"59","author":"Zerimech","year":"2021","journal-title":"Clin Chem Lab Med"},{"key":"2025061801250786000_34.176.240257.132","doi-asserted-by":"crossref","first-page":"AB59","DOI":"10.1016\/j.jaci.2021.12.223","article-title":"Cathepsin G in patients with SARS-Cov-2 infection of various degrees of severity","volume":"149","author":"Beloglazov","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"2025061801250786000_34.176.240257.133","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S2213-2600(22)00261-2","article-title":"Dipeptidyl peptidase-1 inhibition in patients hospitalised with COVID-19: a multicentre, double-blind, randomised, parallel-group, placebo-controlled trial","volume":"10","author":"Keir","year":"2022","journal-title":"Lancet Respir Med"},{"key":"2025061801250786000_34.176.240257.134","doi-asserted-by":"crossref","first-page":"4064","DOI":"10.1038\/s41598-019-40785-2","article-title":"Specific elastin degradation products are associated with poor outcome in the ECLIPSE COPD cohort","volume":"9","author":"R\u00f8nnow","year":"2019","journal-title":"Sci Rep"},{"key":"2025061801250786000_34.176.240257.135","doi-asserted-by":"publisher","DOI":"10.3390\/biom11081065"},{"key":"2025061801250786000_34.176.240257.136","doi-asserted-by":"crossref","first-page":"104936","DOI":"10.1016\/j.ebiom.2023.104936","article-title":"Proteomic signatures of eosinophilic and neutrophilic asthma from serum and sputum","volume":"99","author":"Asamoah","year":"2024","journal-title":"EBioMedicine"},{"key":"2025061801250786000_34.176.240257.137","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2011.10.020"},{"key":"2025061801250786000_34.176.240257.138","doi-asserted-by":"publisher","DOI":"10.3109\/15412555.2011.641803"},{"key":"2025061801250786000_34.176.240257.139","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)60860-1"},{"key":"2025061801250786000_34.176.240257.140","doi-asserted-by":"crossref","first-page":"442022","DOI":"10.3389\/fimmu.2019.00821","article-title":"Mast cells and their progenitors in allergic asthma","volume":"10","author":"M\u00e9ndez-Enr\u00edquez","year":"2019","journal-title":"Front Immunol"},{"key":"2025061801250786000_34.176.240257.141","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.forsciint.2016.11.001","article-title":"Postmortem serum levels of IgE and mast cell tryptase in fatal asthma","volume":"269","author":"Scarpelli","year":"2016","journal-title":"Forensic Sci Int"},{"key":"2025061801250786000_34.176.240257.142","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2022.05.028"},{"key":"2025061801250786000_34.176.240257.143","doi-asserted-by":"crossref","first-page":"101152","DOI":"10.1016\/j.mam.2022.101152","article-title":"Beyond target cell death \u2013 granzyme serine proteases in health and disease","volume":"88","author":"N\u00fcssing","year":"2022","journal-title":"Mol Aspects Med"},{"key":"2025061801250786000_34.176.240257.144","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1239151"},{"key":"2025061801250786000_34.176.240257.145","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s11882-023-01082-1","article-title":"An emerging role of extracellular traps in chronic rhinosinusitis","volume":"23","author":"Zhang","year":"2023","journal-title":"Curr Allergy Asthma Rep"},{"key":"2025061801250786000_34.176.240257.146","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V83386"},{"key":"2025061801250786000_34.176.240257.147","doi-asserted-by":"publisher","DOI":"10.1038\/nm.1959"},{"key":"2025061801250786000_34.176.240257.148","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2021081112"},{"key":"2025061801250786000_34.176.240257.149","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA118.001922"},{"key":"2025061801250786000_34.176.240257.150","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-50747-6"},{"key":"2025061801250786000_34.176.240257.151","doi-asserted-by":"publisher","DOI":"10.1016\/j.biochi.2023.09.018"},{"key":"2025061801250786000_34.176.240257.152","doi-asserted-by":"crossref","first-page":"110531","DOI":"10.1016\/j.cellsig.2022.110531","article-title":"Cathepsins in the extracellular space: focusing on non-lysosomal proteolytic functions with clinical implications","volume":"103","author":"Wang","year":"2023","journal-title":"Cell Signal"},{"key":"2025061801250786000_34.176.240257.153","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-018-0002-3"},{"key":"2025061801250786000_34.176.240257.154","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s12931-020-01381-5","article-title":"Cathepsin S: investigating an old player in lung disease pathogenesis, comorbidities, and potential therapeutics","volume":"21","author":"Brown","year":"2020","journal-title":"Respir Res"},{"key":"2025061801250786000_34.176.240257.155","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201311-1986OC"},{"key":"2025061801250786000_34.176.240257.156","doi-asserted-by":"publisher","DOI":"10.3390\/cells8030264"},{"key":"2025061801250786000_34.176.240257.157","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.171.2.931"}],"container-title":["European Respiratory Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/16000617.0257-2024","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T04:25:19Z","timestamp":1750220719000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/16000617.0257-2024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":157,"journal-issue":{"issue":"176","published-online":{"date-parts":[[2025,6,18]]},"published-print":{"date-parts":[[2025,4]]}},"alternative-id":["10.1183\/16000617.0257-2024"],"URL":"https:\/\/doi.org\/10.1183\/16000617.0257-2024","relation":{},"ISSN":["0905-9180","1600-0617"],"issn-type":[{"value":"0905-9180","type":"print"},{"value":"1600-0617","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4]]}}}